Biological Background of Cytokeratin-8

Cytokeratin-8 (CK8), also referred to as Keratin-8 (KRT8), is a member of the type II (basic/neutral) intermediate filament protein family. In most epithelial tissues, CK8 forms obligate heterodimers with its type I partner Cytokeratin-18 (CK18), creating the structural scaffolding that maintains cell integrity and mechanical resilience.

CK8 is expressed in simple epithelial cells lining the gastrointestinal tract, liver, lung, kidney, and pancreas. Its expression is largely absent in stratified squamous epithelia, making it a valuable discriminatory marker in histopathology. Elevated or aberrant CK8 expression has been reported in a variety of carcinomas, including hepatocellular carcinoma, colorectal carcinoma, and breast carcinoma, supporting its utility as an oncological biomarker.

In research contexts, CK8 detection is routinely employed to confirm epithelial lineage, characterize tumor histotype, monitor epithelial-to-mesenchymal transition (EMT), and validate cell line identity.

Antibody Specifications and Reagent Handling

The Cytokeratin-8 Mouse mAb (Ab348632) is a murine IgG monoclonal antibody raised against Cytokeratin-8 antigen. Key handling recommendations are summarized below:

• Storage: Store the antibody at -20°C upon receipt. For working aliquots used within one to two weeks, storage at 4°C is acceptable. Avoid repeated freeze-thaw cycles, as these can reduce antibody activity and lead to aggregation.
• Formulation: Refer to the product datasheet for exact buffer composition, protein concentration, and carrier protein content, as formulation details may influence dilution calculations.
• Aliquoting: Upon first thaw, prepare single-use aliquots to minimize freeze-thaw cycles. Label aliquots clearly with date and lot number.
• Handling: Keep the antibody on ice during use. Avoid vortexing vigorously; mix gently by pipetting or brief centrifugation.

Note: Always consult the current product datasheet (available on the Aladdin Scientific product page for Ab348632) for the most up-to-date specifications, as lot-specific information may vary.

Recommended Protocols by Application

Immunohistochemistry (IHC)

1. Deparaffinize and rehydrate FFPE sections through a graded alcohol series to water.
2. Perform antigen retrieval using a citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) in a pressure cooker or water bath at 95–100°C for 10–20 minutes. Allow sections to cool to room temperature.
3. Block endogenous peroxidase with 3% hydrogen peroxide in methanol for 10 minutes.
4. Block non-specific binding with 5–10% normal serum (matching the secondary antibody host species) for 30–60 minutes at room temperature.
5. Incubate with the Cytokeratin-8 Mouse mAb at the manufacturer's recommended dilution in blocking buffer. Overnight incubation at 4°C is recommended for optimal signal.
6. Wash three times with PBS-T (0.05% Tween-20) for 5 minutes each.
7. Apply an appropriate HRP-conjugated anti-mouse secondary antibody and incubate for 30–60 minutes at room temperature.
8. Develop with DAB substrate, counterstain with hematoxylin, dehydrate, and mount.

Western Blotting (WB)

1. Prepare cell or tissue lysates in RIPA buffer supplemented with protease inhibitors. CK8 migrates at approximately 52–55 kDa under denaturing conditions.
2. Run 20–40 µg total protein per lane on a 10–12% SDS-PAGE gel.
3. Transfer to PVDF or nitrocellulose membrane.
4. Block with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
5. Incubate with Cytokeratin-8 Mouse mAb at recommended dilution overnight at 4°C.
6. Wash and incubate with HRP-conjugated anti-mouse IgG secondary antibody.
7. Detect with ECL reagent and image on film or digital system.

Immunofluorescence (IF)

1. Fix cells with 4% paraformaldehyde for 15 minutes; permeabilize with 0.1–0.2% Triton X-100 for 10 minutes.
2. Block with 5% BSA or normal serum for 30–60 minutes.
3. Incubate with Cytokeratin-8 Mouse mAb at recommended dilution for 1 hour at room temperature or overnight at 4°C.
4. Wash and apply a fluorophore-conjugated anti-mouse secondary antibody (e.g., Alexa Fluor 488 or 594).
5. Counterstain nuclei with DAPI and mount with anti-fade medium.

Always perform optimization experiments to determine the ideal antibody dilution, antigen retrieval method, and incubation conditions for your specific tissue or cell type.

Troubleshooting Common Issues

Below are common issues encountered when using the Cytokeratin-8 Mouse mAb and recommended corrective actions:

Quality Control and Positive Controls

Robust quality control is essential for reliable results with any monoclonal antibody. For the Cytokeratin-8 Mouse mAb (Ab348632), the following QC practices are recommended:

• Positive control tissues: Liver, colon, or lung tissue sections are suitable positive controls for IHC, as these tissues constitutively express CK8 in simple epithelium.
• Positive control cell lines: Epithelial-derived cell lines such as HeLa, HepG2, MCF-7, or A549 are commonly used as WB and IF positive controls due to their known CK8 expression.
• Negative controls: Replace the primary antibody with an isotype-matched mouse IgG at the same concentration to assess non-specific background staining.
• Internal tissue controls: In histological sections, adjacent stromal cells or lymphocytes, which typically lack CK8 expression, serve as internal negative references.
• Lot documentation: Record antibody lot number, dilution used, and incubation conditions in your experimental notebook for traceability and reproducibility.